Grants and Contributions:

Back to search

Title:

514239

Agreement Number:

514239

Agreement Value:

$23,000,000.00

Agreement Date:

Oct 12, 2023 - Dec 31, 2045

Description:

The project will focus on the activities required for Phase 3 clinical trials/regulatory approval for their novel antibody treatment (EB05) targeting acute respiratory distress syndrome (ARDS), the most common cause of death in COVID-19 patients.

Organization:

Innovation, Science and Economic Development Canada

Expected Results:

The investment will advance Phase III clinical trials for a antibody therapy (EB05), for the treatment of acute respiratory distress syndrome (ARDS) in COVID-19 patients. ARDS is a severe form of respiratory failure with high mortality rate and few treatments available.

Location:

Markham, Ontario, CA L3R5H6

Reference Number:

033-2023-2024-Q3-514239

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

815678123

Recipient Type:

For-profit organization

Additional Information:

Please note these updates include changes to improve standardization of reporting across projects. The original start date was updated to reflect the correct execution date. The end date was updated from the end of the work phase of the project (31/12/2025) to the end of the contract (31/12/2045). The end date now reflects the entirety of the agreement duration, including the benefit phase and residual audit period. The amendment provides for a 36 month extension of the work phase.

Amendment Date

Sep 30, 2025

Recipient's Operating Name:

Edesa Biotech Research, Inc.

Recipient's Legal Name:

Edesa Biotech Research, Inc.

Federal Riding Name:

Markham--Unionville

Federal Riding Number:

35056

Program:

SIF Stream 1- R&D

Program Purpose:

Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.

NAICS Code:

339900

Amendments:

See Amendments